Levocetirizin HEXAL

Quick links

Choose a section

Quick links to important sections

Advertisements

Levocetirizin HEXAL

Advertisements
Advertisements

Overview of Levocetirizin HEXAL

Property Description
Active ingredient Levocetirizine dihydrochloride
Form Oral (Film-coated tablet, oral solution)
Pharmacological class H1-receptor antagonist (Antihistamine)
General purpose Systematic relief of histamine-driven allergic symptoms
Origin Synthetic, R-enantiomer

What Type of Medicine is Levocetirizine? (Classification and Origin)

Levocetirizine dihydrochloride is classified as a potent and selective second-generation antihistamine that acts as an H1-receptor antagonist. It is a synthetic compound intended for oral administration, structurally recognized as the active R-enantiomer of its predecessor, Cetirizine. This structural refinement is characterized by the molecule's affinity for the histamine receptors. The HEXAL branding indicates a pharmaceutical preparation manufactured by the Sandoz/HEXAL group, typically positioned for widespread availability across European markets. Levocetirizine is associated with high affinity binding to peripheral H1-receptors, confirming its focused role in allergy management.

Composition and Physical Forms

The pharmaceutical product, irrespective of its brand, is a single-active ingredient product (monocomponent) containing only Levocetirizine dihydrochloride. The drug is formulated for systemic delivery and is commonly available in standardized oral forms, such as the white film-coated tablet or an aqueous oral solution. The latter form is often considered suitable for patients who have difficulty swallowing solids. The specific use of the dihydrochloride salt is a standard pharmaceutical technique employed to ensure the compound maintains optimal chemical stability and solubility, which is crucial for predictable and reliable absorption into the bloodstream after consumption.

The General Purpose of Levocetirizine

The primary general purpose of this medicine is to provide systematic relief from discomfort and overreactions caused by the body’s release of histamine, a typical neutral use scenario in cases of seasonal or perennial allergy symptoms. Its action is based on selective periphery H1-receptor blocking. By preventing the natural chemical histamine from attaching to its target receptors, Levocetirizine helps to suppress the chain of signals that lead to the physical manifestations of an allergic response. Its classification confirms its core function is to modulate the effects of histamine as the principal mediator of allergic conditions.

Regulatory References

  1. DailyMed Levocetirizine Label
Advertisements

What side effects are possible with Levocetirizin HEXAL?

Possible Side Effects and Safety Information

Levocetirizine dihydrochloride's safety profile is defined by officially documented adverse reactions, classified by frequency and system involvement based on regulatory standards. The incidence and nature of these effects may vary between adults and children.

Documented Adverse Reactions and Frequencies

The most Common adverse reactions, defined as occurring in 1 in 100 to 1 in 10 patients in clinical trials, include effects on the central nervous system and general well-being. These are primarily somnolence (drowsiness), fatigue, and headache. Other common effects include nasopharyngitis, pharyngitis, and dry mouth. Less Uncommon effects, occurring in up to 1 in 100 patients, involve asthenia (weakness) and abdominal pain.

Adverse reactions identified through post-marketing surveillance, whose frequency is generally classified as Not Known, include oculogyration (involuntary eye movement), urinary retention, and severe pruritus (itching) upon discontinuation of the medicine.


Serious Safety Considerations and Restrictions

The official labeling notes a risk of Hypersensitivity reactions, including severe allergic reactions like anaphylaxis. The medicine is Contraindicated in individuals with known hypersensitivity to levocetirizine, cetirizine, or hydroxyzine. Caution is formally advised for patients with predisposing factors for urinary retention, as this reaction has been reported.

Regarding exposure patterns, somnolence is noted as being more likely to occur at the start of therapy. The label explicitly cautions that using levocetirizine with alcohol or other Central Nervous System (CNS) depressants may cause an additional reduction in alertness.


Population-Specific Safety Notes

The risk of adverse reactions is greater in patients with impaired renal function due to how the drug is cleared from the body. Consequently, the medicine is Contraindicated in patients with end-stage renal disease. Furthermore, specific safety cautions apply to pediatric patients (6 months to 11 years) with any degree of renal impairment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The information provided in this section reflects the officially documented descriptions and mandatory emergency actions detailed in government regulatory sources such as the FDA and EMA-aligned prescribing information.

Overdose manifestations are primarily associated with Central Nervous System (CNS) effects. In adults and adolescents, the main documented symptom of overdose is drowsiness (somnolence). However, in children, the official labeling notes a distinct presentation: initial symptoms of agitation or restlessness typically occur first, followed by the subsequent onset of drowsiness.

Overdose management is constrained by the official regulatory statement that no known specific antidote exists for Levocetirizine. Therefore, management is strictly limited to symptomatic and supportive treatment. This includes managing the documented manifestations and maintaining vital functions.

Urgent medical attention must be sought immediately if a suspected overdose has occurred, or if symptoms such as collapse, seizure, severe difficulty breathing, or stupor are present. Regulatory guidance specifies that procedures such as gastric lavage may be considered in cases of recent, large ingestion. It is also documented that Levocetirizine is not effectively removed by dialysis.

Advertisements

Therapeutic Uses of Levocetirizin HEXAL

What Levocetirizine HEXAL Treats: Main Uses and Benefits

Levocetirizine is commonly used to provide supportive symptom management across therapeutic domains where patients experience heightened physiological activity: allergic rhinitis (including seasonal hay fever and persistent perennial types) and certain uncomplicated skin manifestations of chronic urticaria (hives). It is generally applied in clinical settings that involve acute or unstable symptom patterns.

The medication helps address symptom clusters that may become intense or disruptive, such as recurrent sneezing, runny nose, nasal congestion, and itchy, watery eyes associated with allergies. It is also relevant for easing dermal symptoms like the severity of pruritus (intense itching) and the appearance of wheals in chronic hives.

“This approach to symptom management supports the patient during difficult episodes by easing distress and contributing to improved day-to-day comfort.”

This supportive relief is often used during phases when symptoms become more noticeable, and supports the patient’s ability to maintain functional stability when symptoms interfere with routine activities.


Therapeutic Focus: Allergic Discomfort Levocetirizine is commonly used to help with the combined symptomatic burden of both upper airway irritation and dermal allergic reactions.

Regulatory References

  1. NIH DailyMed Drug Label
Advertisements

Eligibility and Restrictions for Use

Levocetirizine's eligibility is determined by official regulatory documents, primarily focusing on age, renal function, and hypersensitivity to the drug and its derivatives.

Populations for Whom Use is Contraindicated

Use is strictly prohibited in specific patient groups:

  • Patients with known hypersensitivity to levocetirizine or any related piperazine derivatives (e.g., cetirizine or hydroxyzine).
  • Patients with end-stage renal disease (ESRD), defined as a creatinine clearance less than 10 mL/min.
  • Children aged 6 months to 11 years with any degree of impaired renal function.

Condition-Based Eligibility and Restrictions

  • Adults and adolescents aged 12 years and older are eligible, but use is conditional in those with mild, moderate, or severe renal impairment, requiring individualized dose modification.
  • The drug is generally not recommended for children younger than 6 months of age, as safety and efficacy have not been established.
  • The tablet formulation is not recommended for children under 6 years due to difficulties in dose adjustment.
  • Use with caution is advised for pregnant women and those with predisposing factors for urinary retention, such as prostatic hyperplasia, as stated in the regulatory label.
Advertisements

What should I know about interactions with other medicines?

Levocetirizine dihydrochloride's official interaction profile is defined by specific pharmacodynamic and pharmacokinetic constraints outlined in regulatory documents. A primary restriction is the avoidance of concurrent use with alcohol and other Central Nervous System (CNS) Depressants. This constraint is imposed to prevent an additive pharmacodynamic effect, which could result in an additional reduction in alertness and impairment of central nervous system performance.

The product’s reliance on the kidneys for clearance leads to critical population-based restrictions. Levocetirizine is contraindicated in patients diagnosed with End-Stage Renal Disease (creatinine clearance less than 10 mL/min) and in pediatric patients (6 months to 11 years) who have impaired renal function. Caution is also noted for use in populations with predisposing factors for urinary retention.

Pharmacokinetic studies documented that the HIV medication Ritonavir significantly increased the systemic exposure of the predecessor compound, cetirizine, a finding relevant to the active drug. Conversely, studies confirmed the absence of clinically relevant interaction with several common medications, including Cimetidine, Erythromycin, and Ketoconazole. Regarding food, regulatory documents confirm that the extent of drug absorption is not reduced when taken with meals, although the rate of absorption is decreased.

Advertisements

Mechanism of Action

Levocetirizine HEXAL is a selective antagonist that modulates key signaling pathways to influence cellular responses driven by specific inflammatory mediators. The drug's action is primarily exerted through two distinct pharmacodynamic domains.

Histamine H1-Receptor Modulation

Levocetirizine is a selective histamine H1-receptor antagonist. It engages H1 receptors expressed on various target cells, including those in the respiratory tract and blood vessels. By binding to the receptor site, it competitively blocks the action of endogenous histamine, a crucial upstream mediator of immediate physiological responses. This interaction inhibits histamine from initiating the intracellular signaling sequences that typically influence vascular permeability and smooth muscle contraction.

Anti-inflammatory Mediator Regulation

Beyond H1-receptor blockade, levocetirizine modulates molecular steps within inflammatory cascades. It engages mechanisms that restrict the release and activity of specific pro-inflammatory mediators, such as cytokines and chemokines, from mast cells, eosinophils, and epithelial cells. This influence on mediator release pathways modifies cellular activity and alters subsequent physiological responses.

Advertisements

Dosage and Administration Information

How to Use Levocetirizin HEXAL

The administration of levocetirizine dihydrochloride is based on established usage parameters that define the route, frequency, and dose adjustments. The medication is intended for the oral route of administration in the form of a 5 mg film-coated tablet or a 0.5 mg/mL oral solution.

Standard Dosing and Frequency

Levocetirizine is administered as a single daily intake, commonly recommended to be taken in the evening. The standard daily dose for adults and adolescents aged 12 years and older is 5 mg. Some patients may be maintained on a lower 2.5 mg dose. For children aged 6 to 11 years, the recommended dose is 2.5 mg once daily; this dose should not be exceeded. The 5 mg tablet is scored to facilitate the administration of this 2.5 mg dose.

Administration Context and Duration

The medicine may be taken with or without food. The tablet should be swallowed whole with liquid. If a dose is missed, it should not be doubled, and the next dose should be taken at the regularly scheduled time.

The duration of use is determined by the nature of the condition: treatment may be intermittent for temporary, seasonal issues (discontinuing when symptoms subside) or continuous for persistent allergic rhinitis, with documented use for up to six months.

Population-Specific Adjustments

Dosing requires adjustment for patients with renal impairment, as the drug is primarily eliminated by the kidneys. For adults and adolescents with kidney impairment, the dose and/or frequency are reduced based on the patient's creatinine clearance to prevent drug accumulation. For example, the dose is often reduced to 2.5 mg once every other day for moderate renal impairment. No dose adjustment is required for patients with solely hepatic impairment.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Levocetirizin HEXAL

Relief of nasal and ocular symptoms of seasonal allergic rhinitis

Studies exploring the use of levocetirizine for seasonal allergic rhinitis (often called hay fever) are often based on randomized, controlled trials. In these types of studies, people with hay fever symptoms are randomly assigned to receive either levocetirizine or a neutral substance called a placebo. The main goal is to compare the impact of the treatment on symptoms like sneezing, runny nose, itchy nose, and itchy/watery eyes.

Research so far indicates that studies suggest an association with improvement in the overall symptoms reported by people with seasonal allergic rhinitis. In some studies, improvements in symptoms were recorded relatively quickly after receiving the medication. These findings suggest that levocetirizine use was associated with outcomes related to managing the discomfort caused by seasonal exposure to allergens like pollen.


Relief of nasal and ocular symptoms of perennial allergic rhinitis

The evidence for perennial allergic rhinitis—symptoms that occur year-round, often from indoor allergens like dust mites or pet dander—comes from similar study designs, including randomized, placebo-controlled trials. The research often tracks patient-reported symptoms over a longer continuous period compared to seasonal allergy studies.

The main findings suggest an association between levocetirizine and the reporting of symptom reduction, which included nasal congestion, for people with perennial allergic rhinitis. Some long-term studies, lasting several months, recorded that the reported symptom reduction continued throughout the study period.


Relief of symptoms of chronic idiopathic urticaria (hives of unknown cause)

Research into the use of levocetirizine for chronic idiopathic urticaria, which are persistent hives with no clear trigger, typically involves clinical trials where the severity of itching, the number of hives (wheals), and the size of the wheals are measured and compared against a placebo.

Studies suggest an association between levocetirizine and a reduction in the severity of the itching and the number/size of the hives in people with this condition. The research has mainly focused on treatment periods of several weeks, and the results were consistent with an improvement in overall skin symptoms and related discomfort.


Evidence for Special Populations (Children, Elderly, Patients with Renal/Hepatic Impairment)

Research has explored the use of levocetirizine in children for both allergic rhinitis and chronic urticaria. These studies examined symptom changes and found results suggesting an association with symptom relief in younger age groups (typically 6 years and older) similar to what has been observed in adults. However, for children under 6, particularly infants, the evidence is more limited, and the existing formulation does not easily allow the individualized dose adjustments that would be needed for smaller children.

For the elderly population, research has indicated that if kidney function is normal, the evidence suggests that the observed symptom changes in these older patients were similar to those reported by younger adults. For patients with renal (kidney) impairment, the evidence is less conclusive due to fewer dedicated studies. For patients with only hepatic (liver) impairment, studies suggest that dose adjustment may not be necessary.

Key Studies & References

  1. Clinical Study NCT00291642: A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR)
  2. Levocetirizine Dihydrochloride Tablets: DailyMed (FDA-related labeling on renal impairment and pediatrics)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Levocetirizin HEXAL (FAQ)

Q: What is the main difference between Levocetirizin HEXAL and regular cetirizine?

A: Levocetirizine is described in official regulatory documents as the active component, or R-enantiomer, of cetirizine. Cetirizine itself is a racemic mixture, meaning it contains two mirror-image components. Levocetirizine isolates only the component that is active in the body.


Q: Can children of all ages use Levocetirizin HEXAL?

A: Official product information for levocetirizine includes approved use for specific indications in children as young as 6 months of age, typically through the oral solution formulation. Decisions about eligibility and administration for younger children are addressed by regulatory guidelines and are typically determined by a healthcare professional.


Q: Can taking Levocetirizin HEXAL relieve itchy eyes?

A: According to the official product labeling, this medication is indicated to temporarily relieve symptoms due to hay fever or other respiratory allergies. These symptoms often include itchy, watery eyes and itching of the nose or throat.


Q: Is Levocetirizin HEXAL effective for symptoms other than sneezing and runny nose?

A: Yes, official regulatory indications go beyond common respiratory symptoms. The medication is also indicated for the treatment of uncomplicated chronic idiopathic urticaria, which is the medical term for chronic hives.


Q: What is the role of Levocetirizin HEXAL in treating perennial allergic rhinitis?

A: Official documents define the drug’s role as the symptomatic treatment of both seasonal allergic rhinitis and perennial (year-round) allergic rhinitis. This means it is officially described for use in managing allergy symptoms that persist throughout the year.


Q: Is Levocetirizin HEXAL known to cause weight gain?

A: Official product information lists 'weight increased' as an uncommon side effect. This means it was reported in a low percentage of patients (between 0.1% and 1%) during the clinical trials.


Q: How quickly can I expect to notice the effects of Levocetirizin HEXAL?

A: Studies examining the medication’s onset of action have shown that a decrease in nasal symptoms has occurred as soon as 1 hour following the administration of a single dose.


Q: Does Levocetirizin HEXAL make you drowsy or sleepy?

A: Sleepiness (somnolence) and fatigue are officially listed as common side effects in the product information for adults and adolescents. Official warnings note that individuals are advised to exercise caution when engaging in activities that require mental alertness.


Q: What are the most common side effects reported for Levocetirizin HEXAL?

A: According to official regulatory sources, the most frequently reported common side effects in clinical trials for adults and adolescents include sleepiness, fatigue, dry mouth, and nasopharyngitis (inflammation of the nose and throat).


Q: Is it possible to become dependent on Levocetirizin HEXAL if taken long-term?

A: Official warnings do not address dependence on the medication. However, regulatory documents note that severe generalized itching (pruritus) has been reported in some patients upon discontinuation after long-term daily use.


Q: Does Levocetirizin HEXAL affect concentration or the ability to drive?

A: Official warnings state that drowsiness may occur. Official warnings indicate that individuals should determine how the medication affects them before undertaking activities such as operating a motor vehicle or machinery.


Q: Is Levocetirizin HEXAL considered safe during pregnancy?

A: Official regulatory documents categorize the drug under the former FDA Pregnancy Category B. The drug's labeling states that it should be used during pregnancy only if it is clearly needed.


Q: Is Levocetirizin HEXAL the same kind of drug as diphenhydramine (Benadryl)?

A: No, Levocetirizine is classified as a second-generation H1-antihistamine. It is described as being less likely to cause noticeable drowsiness than older medications like diphenhydramine, which is a first-generation H1-antihistamine.


Q: What kind of research evidence is available for the use of Levocetirizin HEXAL in chronic hives (urticaria)?

A: The official indication for chronic idiopathic urticaria is supported by the results of multiple clinical trials. These studies have examined the efficacy and safety of the medication in the specific context of managing chronic hives.


Q: Is it normal to feel a dry mouth after taking Levocetirizin HEXAL?

A: Yes, regulatory product information lists dry mouth as a common side effect of the medication. This means it has been reported by a measurable percentage of users in clinical studies.


Q: Can Levocetirizin HEXAL be used for food allergy reactions?

A: The official indications listed in regulatory documents are for symptoms of seasonal/perennial allergic rhinitis and chronic idiopathic urticaria. Acute food allergy reactions are not listed as an approved use for this medication.


Q: Are there any specific warnings for older adults using Levocetirizin HEXAL?

A: Official warnings state that the drug should be used with caution in older adults. This caution is advised particularly due to the potential for urinary retention in this population.


Q: Does Levocetirizin HEXAL have a sedative effect compared to other second-generation antihistamines?

A: Levocetirizine is a second-generation antihistamine, a group of drugs developed to cross the blood-brain barrier less readily. This generally results in a lower potential for sedation compared to the older first-generation antihistamines.


Q: What are the official sources of information about Levocetirizin HEXAL's side effects?

A: The most comprehensive and authoritative information on side effects is published by governmental regulatory bodies. Key sources include the drug’s FDA Prescribing Information (or DailyMed) and the EMA Summary of Product Characteristics (SmPC).


Q: Does Levocetirizin HEXAL have any known interactions with herbal supplements?

A: Official documents describe interactions with specific drugs and general classes like Central Nervous System (CNS) Depressants. The official interaction profile does not provide specific information regarding general herbal supplements.


Q: Is it possible for Levocetirizin HEXAL to cause headache as a side effect?

A: Yes, official product information lists headache as a common side effect. It is one of the more frequently reported adverse reactions identified in clinical studies.


Q: Does Levocetirizin HEXAL have any effect on blood pressure?

A: Official regulatory documents list uncommon or rare side effects that may affect the cardiovascular system. These include reports of tachycardia (fast heart rate) and hypotension (low blood pressure).


Q: Are there research studies comparing long-term use versus short-term use of Levocetirizin HEXAL?

A: Clinical experience has supported the use of the medication for up to six months. Regulatory documents have also noted adverse events, such as severe itching, associated with discontinuation after long-term daily use.


Q: How is the safety of Levocetirizin HEXAL monitored by regulatory bodies?

A: The safety of the drug is continuously monitored by regulatory bodies like the FDA through mechanisms that collect post-marketing reports from users and healthcare providers. These processes can lead to updates in the official warnings and labeling.


Q: Can Levocetirizin HEXAL cause unusual mood changes or mental side effects?

A: Official documents list less common side effects that may affect the nervous system or mental state. These include reports of hallucinations, depression, and aggressiveness.


Q: Are there any known issues with stopping Levocetirizin HEXAL suddenly?

A: Official warnings indicate that severe generalized itching (pruritus) has been reported in some patients within several days after stopping the drug. This effect has been associated with discontinuation following long-term use.


Q: Is Levocetirizin HEXAL used to treat common colds?

A: No, the official indications are for the temporary relief of symptoms due to hay fever or other respiratory allergies. The medication is not indicated as a treatment for common colds.


Q: What official warnings exist regarding the use of Levocetirizin HEXAL and operating machinery?

A: Official warnings state that drowsiness may occur with use. For this reason, caution should be exercised when operating machinery or performing other tasks that require full mental alertness.


Q: What is the difference between an H1-receptor antagonist and an H2-receptor antagonist?

A: Levocetirizine is an H1-receptor antagonist, meaning it works by blocking the action of histamine at H1 receptors, which are involved in allergic responses. H2-receptor antagonists, by contrast, target H2 receptors primarily involved in the production of stomach acid.


Q: What is the general purpose of taking an antihistamine like this?

A: The general purpose of taking this type of medication is to temporarily relieve common allergy symptoms such as a runny nose, sneezing, or itchy eyes. It works by blocking the effects of histamine in the body.


Q: Do other medications need to be stopped when starting Levocetirizin HEXAL?

A: Official information provides specific interactions with certain drugs (e.g., Ritonavir) and warns against concurrent use with alcohol and other Central Nervous System (CNS) Depressants. This warning is due to the potential for increased drowsiness or impairment.


Q: What is the safety profile of Levocetirizin HEXAL in breastfeeding women?

A: Official resources note that levocetirizine is expected to be excreted into human milk. Regulatory information indicates that large doses or prolonged use may potentially cause drowsiness in the infant or decrease milk supply.


Q: Can people with asthma generally use Levocetirizin HEXAL?

A: The official indications are for allergic rhinitis and urticaria. Studies have examined the use of the drug in patients with allergic rhinitis who also have concomitant asthma, but the drug is not indicated as a treatment for asthma itself.

Advertisements

How should Levocetirizin HEXAL be stored and disposed of?

How to Store and Dispose of Levocetirizin HEXAL?

The official storage and disposal requirements for Levocetirizine HEXAL are mandated by regulatory authorities to preserve drug quality and ensure safety.

Official Storage Requirements

Storage Factor Regulatory Requirement
Temperature Store at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F).
Environment Keep away from heat, moisture, and direct light. The oral solution must be kept from freezing.
Stability The oral solution has a required in-use stability of 3 months after first opening.
Protection Keep out of the sight and reach of children (mandatory warning).

Official Disposal Instructions

Expired or unused medication must be disposed of in accordance with local requirements. Medicines must not be thrown away via wastewater or household waste. Consult a pharmacist for proper disposal methods. If a take-back program is unavailable, some regulatory guidance suggests mixing the product with an undesirable substance before sealing and discarding it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levocetirizin HEXAL found in:

A-Z Index: